Quick Answer
BELITE BIO, INC reported Net Income Loss of -$77.61 million for the year ending 2025.
- BELITE BIO, INC showed a decrease of -114.7% in Net Income Loss from 2024 to 2025.
- This data is from BELITE BIO, INC's annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 6 years of available data (2020 to 2025), BELITE BIO, INC's Net Income Loss has declined by 1,249.1%.
- Historical annual values: Fiscal year 2025: -$77.61 million | Fiscal year 2024: -$36.14 million | Fiscal year 2023: -$31.63 million | Fiscal year 2022: -$12.65 million | Fiscal year 2021: -$9.67 million | Fiscal year 2020: -$5.75 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: